Article
Truncated APC impairs innate immune response by targeting MAVS on mitochondria in colorectal cancer.
Journal of translational medicine - 10 Nov 2025
Li Si-Yu, Wang Xin-Yi, Wang Jing, Cao Jing-Hua, Lv Yong-Rui, Xie Dan, Wang Feng-Wei
Abstract excerpt
BACKGROUND: Most mutant adenomatous polyposis coli (APC) gene produced truncated APC protein (Trunc-APC), which has been shown to function as an oncogene in colorectal cancer (CRC) pathogenesis; however, its role in modulating innate immune responses within tumor cells remains unexplored. METHODS: We utilized CRISPR-Cas9 to knockout mutant APC and performed transcriptome sequencing across multiple CRC cell lines...
Topics
Join the communities discussing this publication.
